Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial ( INICOM study).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 87, doi. 10.1111/dom.12787
- By:
- Publication type:
- Article